Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890588 · ClinicalTrials.gov registry record · NA
Chronic Kidney Disease Clinical Decision Support
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 6,295
- Enrollment target
NCT03890588: Completed NA study, sponsored by HealthPartners Institute.
NCT03890588 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 6,295 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (349% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03890588, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,295 participants
- Enrollment target
Study Summary
To prevent serious chronic kidney disease (CKD) complications such as end-stage renal disease and cardiovascular events, better strategies are needed to identify, treat, and refer CKD patients seen in primary care clinics. This project expands an existing and successful Web-based clinical decision support (CDS) system to include key elements of CKD care and rigorously assesses the impact of this intervention on quality of CKD care for patients seen in primary care settings, including better recognition of CKD, better management of blood pressure and glucose, and more timely referral to nephrologists when appropriate. This low-cost and highly scalable intervention has high potential to improve CKD care and translate massive public and private sector investments in health informatics into tangible health benefits for large numbers of patients with CKD.
Primary Outcome
Number of patients who had a CKD diagnosis document in the 18 months post index.
Interventions
- OTHER CKD enhanced clinical decision support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,295 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2021-09-29 |
| Phase | NA |
What the finished NCT03890588 record still lists
NCT03890588 is an interventional study that assigns participants to a tested intervention. Its 6,295 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (349% higher).
The record links to 0 conditions, and to 1 intervention - of which CKD enhanced clinical decision support is the first listed.
NCT03890588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03890588 about?
NCT03890588 is a clinical study titled "Chronic Kidney Disease Clinical Decision Support". To prevent serious chronic kidney disease (CKD) complications such as end-stage renal disease and cardiovascular events, better strategies are needed to identify, treat, and refer CKD patients seen in primary care clinics. This project expands an existing and successful Web-based clinical decision s...
What is the current status of trial NCT03890588?
This trial is currently completed. It is a NA study. The enrollment target is 6,295 participants. The study started on 2019-04-17. Estimated completion is 2021-09-29.
What interventions are being tested in trial NCT03890588?
The interventions under investigation include: CKD enhanced clinical decision support (OTHER).
Who is sponsoring clinical trial NCT03890588?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03890588's enrollment target sits among peer trials
6,295 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04884802 · 6,254 participants · NA
The GUARDIAN Trial
- NCT03960099 · 6,250 participants · NA
Pictographs for Preventing Wrong-Patient Errors in NICUs
- NCT05440851 · 6,250 participants · NA
Platform of Randomized Adaptive Clinical Trials in Critical Illness
- NCT06566170 · 6,250 participants
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI